Pharmacies - Timor-Leste

Timor-Leste

In Timor-Leste, the revenue in the Pharmacies market is anticipated to reach US$13.65m in 2024.
It is projected to exhibit an annual growth rate (CAGR 2024-2029) of 3.78%, leading to a market volume of US$16.43m by 2029.
When compared globally, United States is expected to generate the highest revenue in this market, amounting to US$387.30bn in 2024.
Furthermore, in terms of per person revenues, US$9.89 will be generated in 2024.
The pharmacy market in Timor-Leste is experiencing a significant growth due to an increasing demand for access to healthcare services and medications.

Key regions: United States, China, Germany, Japan, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmacies market in Timor-Leste is experiencing significant growth and development due to various factors.

Customer preferences: Customers in Timor-Leste have shown a growing preference for accessing healthcare services through pharmacies. This is primarily driven by the convenience and accessibility that pharmacies offer. With the limited number of healthcare facilities in the country, pharmacies have become a popular choice for Timorese people to seek medical advice and purchase essential medications. Additionally, customers appreciate the personalized service and expertise provided by pharmacists, who are often seen as trusted healthcare professionals.

Trends in the market: One major trend in the pharmacies market in Timor-Leste is the increasing demand for over-the-counter (OTC) medications and health products. As the awareness of self-care and preventive healthcare grows among the population, there is a rising demand for products such as vitamins, supplements, and personal care items. Pharmacies are expanding their product offerings to cater to these evolving customer preferences. Another trend in the market is the growing presence of international pharmacy chains in Timor-Leste. These chains bring with them a wider range of products and services, as well as standardized operating procedures. This has led to increased competition among pharmacies, resulting in improved quality and a greater emphasis on customer service. The entry of international players has also contributed to the overall growth and development of the pharmacies market in the country.

Local special circumstances: Timor-Leste is a developing country with a relatively small population and limited healthcare infrastructure. The government has recognized the importance of pharmacies in providing accessible healthcare services to the population and has implemented policies to support their growth. For example, there have been initiatives to improve the regulatory framework for pharmacies and to enhance the training and certification of pharmacists. These efforts have created a favorable environment for the expansion and development of the pharmacies market in Timor-Leste.

Underlying macroeconomic factors: The overall economic growth and increasing disposable income in Timor-Leste have also contributed to the development of the pharmacies market. As people's purchasing power improves, they are more willing to spend on healthcare products and services. This has led to an increase in the demand for pharmaceuticals and other healthcare products, driving the growth of the pharmacies market. In conclusion, the pharmacies market in Timor-Leste is experiencing significant growth and development due to customer preferences for convenient and accessible healthcare services, the increasing demand for OTC medications and health products, the entry of international pharmacy chains, local government support, and underlying macroeconomic factors such as economic growth and increasing disposable income. These factors are driving the expansion and improvement of the pharmacies market, benefiting both customers and the overall healthcare system in Timor-Leste.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.